The increasing incidence of target diseases, such as HIV/AIDS, Hepatitis B, Lyme disease, etc., among individuals across the globe is one of the primary factors driving the western blotting market. In addition to this, the rising governmental expenditure on medical diagnostics and biotechnology sectors is acting as another significant growth-inducing factor.